September 25, 2009 — The Advisory Committee on Immunization Practices (ACIP) has updated and replaced its previous recommendations for revaccinating persons at prolonged increased risk for ...

Children aged 2 to 10 years with HIV responded well with few adverse events to the quadrivalent meningococcal vaccine, according to study results. The trial was conducted because children with HIV are ...

December 7, 2011 — Adolescents should be routinely immunized with the quadrivalent meningococcal conjugate vaccine (MCV4) at 11 or 12 years of age and receive a booster dose at age 16 years, according ...

Mar. 23 -- FRIDAY, Jan. 11 (HealthDay News) -- Expanded use of the FluMist vaccine for children and revised meningococcal vaccination guidelines for teens are part of new immunization recommendations ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. SCOTTSBORO, Ala. – Officials with the ...

Meningococcal disease is a bacterial infection that can cause meningitis, sepsis, pneumonia, or joint infections. Meningococcal disease can be quite severe and may result in brain damage, hearing loss ...

A Camden woman has tested positive for meningococcal disease, according to the Camden County Health Department and New Jersey Department of Health and Human Services. The woman is recovering, and her ...

Pfizer Inc. (NYSE:PFE) announced today that researchers presented for the first time data from a randomized, controlled Phase 2 study of its meningococcal serogroup B vaccine, TRUMENBA®, ...

The quadrivalent meningococcal conjugate vaccine appeared safe for use and effective at preventing disease in adolescents with HIV, although response rates still remained lower than in healthy ...